EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis

Shelby Waddell, Guannan Zhao, Ziping Liu, Hao Chen, Wenjing Zhang, Yaohong Wang, Duane D Miller, Junming Yue, Wei Li

The Journal of Pharmacology and Experimental Therapeutics · 2025-01 · 392 (1) · 100006

DOI: 10.1124/jpet.124.002298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2025-01. Verfasst von Shelby Waddell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Tubulin Modulators, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Health Science Center, University of Tennessee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTubulin ModulatorsAntineoplastic AgentsFemaleAnimalsHumansMiceCell Line, TumorCell ProliferationAdministration, OralMice, NudeNeoplasm MetastasisApoptosisCell MovementXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Liver metastasisOrthotopic mouse modelOvarian cancerTubulin inhibitors

Substanzen

Tubulin ModulatorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Department of Pathology and Laboratory Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee; Center for Cancer Research, University of Tennessee Health Science Center, Memphis…
  • Genetics and Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee; Drug Discovery Center, College of Pharmacy, University of Tennessee Health Science Center, M…

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Health Science Center, University of Tennessee
  • National Institutes of Health
  • US Department of Defense

Zitieren

APA

Waddell, S., Zhao, G., Liu, Z., Chen, H., Zhang, W., Wang, Y., Miller, D. D., Yue, J., & Li, W. (2025). VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis. The Journal of Pharmacology and Experimental Therapeutics, 392(1), 100006. https://doi.org/10.1124/jpet.124.002298

Vancouver

Waddell S, Zhao G, Liu Z, Chen H, Zhang W, Wang Y, et al. VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis. The Journal of Pharmacology and Experimental Therapeutics. 2025;392(1):100006. doi:10.1124/jpet.124.002298

BibTeX
@article{Waddell2025,
  author = {Waddell, Shelby and Zhao, Guannan and Liu, Ziping and Chen, Hao and Zhang, Wenjing and Wang, Yaohong and Miller, Duane D and Yue, Junming and Li, Wei},
  title = {VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2025},
  volume = {392},
  number = {1},
  pages = {100006},
  doi = {10.1124/jpet.124.002298}
}
Kostenlos starten →